| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Abrdn PLC
Abrdn PLC
LSE:ABDN
Abrdn PLC
Cash Equivalents
Abrdn PLC
Cash Equivalents Peer Comparison
III
SDR
ICP
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abrdn PLC
LSE:ABDN
|
Cash Equivalents
£505m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
3i Group PLC
LSE:III
|
Cash Equivalents
£358m
|
CAGR 3-Years
18%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-6%
|
|
|
Schroders PLC
LSE:SDR
|
Cash Equivalents
£3.6B
|
CAGR 3-Years
2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
H
|
Hargreaves Lansdown PLC
LSE:HL
|
Cash Equivalents
£368m
|
CAGR 3-Years
16%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
Intermediate Capital Group PLC
LSE:ICP
|
Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Abrdn PLC's Cash Equivalents?
Cash Equivalents
505m
GBP
Based on the financial report for Dec 31, 2023, Abrdn PLC's Cash Equivalents amounts to 505m GBP.
What is Abrdn PLC's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
1%
Over the last year, the Cash Equivalents growth was 35%. The average annual Cash Equivalents growth rates for Abrdn PLC have been -13% over the past three years , 1% over the past five years .
You don't have any saved screeners yet
